BRCA Mutations and Cancer Risk: What You Need to Know

Mutations are changes in DNA that occur naturally over time. Most are harmless, but some can have a significant impact on health. One such example is mutations in the BRCA1 or BRCA2 genes, which can greatly increase the risk of developing breast, ovarian, and certain other cancers. However, having a BRCA mutation does not mean cancer is inevitable; it only indicates a higher risk and the need for closer vigilance. To help you understand this critical link between BRCA mutations and cancer risk, this blog covers what these mutations really mean, the tests available to detect them, and who should consider genetic testing. Let’s start by understanding the role of BRCA genes in our body.

What are BRCA Genes?

BRCA genes are a pair of genes, BRCA1 (Breast Cancer gene 1) and BRCA2 (Breast Cancer gene 2), that play an important role in maintaining the stability of a cell’s genetic material. They help repair damaged DNA and prevent cells from growing uncontrollably. In their normal form, these genes act as tumour suppressors, reducing the likelihood of cancer development.

How Does Mutations in BRCA Gene Increase Susceptibility to Cancer Development?

Mutations in the BRCA1 or BRCA2 genes interfere with their natural ability to repair damaged DNA. Under normal conditions, these genes act as part of the body’s defence system, fixing DNA breaks that occur during cell division and preventing abnormal cell growth. When a mutation occurs, this repair process becomes less effective or stops altogether. As a result, damaged DNA accumulates within cells, increasing the likelihood of uncontrolled growth and tumour formation. Over time, this can lead to the development of cancers such as breast, ovarian, prostate, and pancreatic cancer. The higher susceptibility is not because the mutation directly causes cancer, but because it weakens the body’s natural mechanisms that keep harmful cell changes under control.

Which Cancers are Linked to BRCA Mutations?

Mutations in the BRCA1 and BRCA2 genes are associated with an increased risk of several types of cancer. These mutations affect both men and women, though the degree of risk and the type of cancer may vary depending on the gene involved.

• Breast Cancer: The most well-known association of BRCA mutations is with breast cancer. Women carrying a BRCA1 or BRCA2 mutation face a significantly higher lifetime risk compared to the general population. The cancer often develops at a younger age and may affect both breasts (bilateral breast cancer). Men with BRCA2 mutations are also at an increased risk of developing male breast cancer, which, although rare, can occur when the gene’s protective function is lost.
• Ovarian Cancer: BRCA mutations, particularly in BRCA1, are strongly linked to ovarian cancer. These mutations affect the cells lining the ovaries and fallopian tubes, leading to a higher risk of developing this type of cancer earlier in life. Ovarian cancer caused by BRCA mutations can be more aggressive but is often identified through genetic testing in families with a history of the disease.
• Prostate Cancer: Men with BRCA2 mutations face an increased risk of developing prostate cancer, which may occur at a younger age and progress more rapidly than usual. BRCA1 mutations are also linked, though to a lesser extent. Regular prostate-specific antigen (PSA) testing and medical evaluations are often recommended for men with a family history of BRCA-related cancers.
• Pancreatic Cancer: Both BRCA1 and BRCA2 mutations are associated with a higher likelihood of pancreatic cancer. Although less common than breast or ovarian cancer, pancreatic cancer linked to these mutations can run in families. Early detection remains difficult, which makes genetic testing valuable for individuals with a strong family history of this disease.
• Other Possible Cancers: Research has shown potential links between BRCA mutations and other cancers, such as melanoma (especially linked to BRCA2) and certain types of stomach or bile duct cancers. These associations are less well established but continue to be studied as more genetic data becomes available.

How Can BRCA Gene Mutations Be Identified?

Testing for BRCA1 and BRCA2 mutations helps determine if a person has inherited genetic changes that increase their risk of developing certain cancers. The process includes pre-test counselling, the actual test, and a review of the results with a specialist.

• Genetic Counselling: Before undergoing BRCA testing, individuals usually meet a genetic counsellor or an oncologist. The session involves discussing family and personal medical history to assess the likelihood of hereditary cancer risk. Counselling helps individuals understand the purpose of the test, its possible outcomes, and how the results might affect medical or preventive decisions. It also provides emotional support, as learning about genetic risk can sometimes be overwhelming.
• The Genetic Test: The test is simple and non-invasive. It requires a blood or saliva sample, which is sent to a specialised laboratory for DNA analysis. The lab examines the BRCA1 and BRCA2 genes to identify harmful mutations that interfere with normal DNA repair. The process typically takes a few weeks, depending on the testing facility and method used.
• Interpreting the Results: Once the sample is analysed, results are reported as positive, negative, or variant of uncertain significance (VUS). A positive result indicates a mutation that increases cancer risk, while a negative result shows no known harmful change. A VUS result means a genetic variation is present, but its impact on cancer risk is unclear. The genetic counsellor or oncologist explains these outcomes and guides further action based on the findings.

Who Should Consider BRCA Testing?

BRCA testing is not recommended for everyone but is advised for individuals or families where there are signs of a hereditary cancer pattern.

• Family History of Certain Cancers: People with multiple relatives diagnosed with breast, ovarian, prostate, or pancreatic cancer on the same side of the family are more likely to carry BRCA mutations. The risk increases further if these cancers occurred across several generations.
• Early-Onset Cancer in the Family: Individuals with relatives diagnosed with breast cancer before the age of 50 or ovarian cancer at any age should consider genetic testing. Early-onset cancers often point to a hereditary cause rather than random occurrence.
• Male Breast Cancer: Although rare, male breast cancer can be linked to BRCA2 mutations. Men with this diagnosis, or those with close male relatives who have had it, are advised to consider testing.
• Multiple or Bilateral Cancers: Testing is often recommended when a person or close relative has experienced cancer in both breasts or multiple types of cancer, such as breast and ovarian cancer. This pattern may indicate an inherited mutation affecting both organs.
• Ashkenazi Jewish Ancestry: People of Ashkenazi Jewish descent have a higher chance of carrying specific BRCA1 or BRCA2 mutations that are more common in this population. Testing is often suggested even with limited family history.
• Known BRCA Mutation in the Family: If a family member has already tested positive for a BRCA mutation, other close relatives are strongly advised to undergo testing. This helps identify who may share the inherited risk and benefit from preventive care.

Consult Today

If you have a family history of breast, ovarian, or related cancers, or if you’re simply concerned about your genetic risk, it might be worth discussing BRCA testing with a medical professional. They can help you understand your personal risk, interpret test results, and guide you through the next steps if needed. You can schedule a consultation with a genetic counsellor or oncologist at Max Hospital to talk through your options and get reliable guidance tailored to your case.

Frequently Answered Questions

Can BRCA mutations skip generations?

No, BRCA mutations do not skip generations. However, it might appear so if family members carrying the mutation never developed cancer.

If my BRCA test is negative, does that mean I have no cancer risk?

A negative result only means you don’t have the known BRCA mutations. It doesn’t eliminate your risk of developing cancer from other genetic or environmental factors.

How accurate are BRCA tests?

BRCA tests are highly accurate in detecting mutations, though their interpretation should always be done by a qualified genetic counsellor to ensure correct understanding of the results.

What does an inconclusive BRCA test result mean?

It means the test found a variant of uncertain significance (VUS). In such cases, more research or family testing may be needed to determine its impact.

Can BRCA mutations influence treatment choices for cancer patients?

Yes, knowing BRCA status can help doctors decide on specific treatment plans, such as using targeted therapies like PARP inhibitors for certain cancers.

Can I develop a BRCA mutation later in life?

No, BRCA mutations are inherited and present from birth. However, other genetic changes unrelated to BRCA can occur later due to environmental or lifestyle factors.

Should my family members get tested if I have a BRCA mutation?

Yes, since BRCA mutations are hereditary, close relatives such as siblings, parents, or adult children may consider genetic testing to assess their own risk.

How often should someone with a BRCA mutation go for cancer screening?

Screening frequency depends on the individual’s age, medical history, and risk level. Genetic counselors or oncologists can recommend a suitable screening plan.